Search research articles
Contact Us
Filters
Showing results (41-50 of 116) with videos related to
Page
of 12
Sort By:
Plos One
|
March 17, 2026
Long-text caption generation for surgical image with a concept retrieval augmented large multimodal model
Jiquan Liu, Yichen Zhu, Jingyi Feng, et al.
Plos One
|
May 22, 2014
Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1
Jun Lin, Qiang Zhang, Yi Lu, et al.
Journal of Orthopaedic Surgery and Research
|
September 28, 2024
Clinical efficacy of endoscopic debridement combined with compression suture in the treatment of recalcitrant aseptic olecranon bursitis
Shiyun Shen, Tianshun Fang, Jiabao Dong, et al.
BMC Nephrology
|
July 25, 2019
Post-surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10-year results from the US National Inpatient Sample
Chen Ning, Xinyi Hu, Fangming Liu, et al.
ACS Nano
|
April 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy
Citradewi Soemardy, Yan-Ruide Li, Yichen Zhu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
March 10, 2017
Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer
Wei Qiu, Jun Lin, Yichen Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 4, 2022
Mucosal-associated invariant T cells for cancer immunotherapy
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy Oncolytics
|
October 25, 2023
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Frontiers in Medicine
|
April 17, 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
Yuning Chen, Yichen Zhu, Adam Kramer, et al.
Leukemia
|
March 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia
Yan-Ruide Li, Xinyuan Shen, Yuning Chen, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 116) with videos related to
Sort By:
Page
of 12
Plos One
|
March 17, 2026
Long-text caption generation for surgical image with a concept retrieval augmented large multimodal model
Jiquan Liu, Yichen Zhu, Jingyi Feng, et al.
Plos One
|
May 22, 2014
Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1
Jun Lin, Qiang Zhang, Yi Lu, et al.
Journal of Orthopaedic Surgery and Research
|
September 28, 2024
Clinical efficacy of endoscopic debridement combined with compression suture in the treatment of recalcitrant aseptic olecranon bursitis
Shiyun Shen, Tianshun Fang, Jiabao Dong, et al.
BMC Nephrology
|
July 25, 2019
Post-surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10-year results from the US National Inpatient Sample
Chen Ning, Xinyi Hu, Fangming Liu, et al.
ACS Nano
|
April 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy
Citradewi Soemardy, Yan-Ruide Li, Yichen Zhu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
March 10, 2017
Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer
Wei Qiu, Jun Lin, Yichen Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 4, 2022
Mucosal-associated invariant T cells for cancer immunotherapy
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy Oncolytics
|
October 25, 2023
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Frontiers in Medicine
|
April 17, 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
Yuning Chen, Yichen Zhu, Adam Kramer, et al.
Leukemia
|
March 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia
Yan-Ruide Li, Xinyuan Shen, Yuning Chen, et al.
Page
of 12